Simple Summary Despite remarkable progress being made by preventive medical check-
ups in the last decades, colorectal cancer (CRC) remains one of the most frequent and …

Colorectal cancer (CRC) is the third most common cancer and leading cause of cancer
related deaths worldwide. Despite recent advancements in surgical and molecular targeted …

BACKGROUND: Glycolysis was an essential driver of chemo-resistance in colorectal cancer
(CRC), albeit with limited molecular explanations. OBJECTIVE: We strived to elucidate the …

The resistance of cancer cells into chemotherapy has restricted the efficiency of anti-tumor
drugs. Oxaliplatin (OX) being an anti-tumor agent/drug is extensively used in the treatment of …

This study explored the function and mechanisms of HOX transcript antisense RNA
(HOTAIR) in the drug resistance of nasopharyngeal carcinoma (NPC). Quantitative PCR …

Colorectal cancer (CRC) accounts for one of the main cancer‐related mortality and morbidity
worldwide. The molecular mechanisms of CRC development have been broadly …

Glioma is the most common primary intracranial malignant tumour in adults. It has a high
incidence and poses a serious threat to human health. Circular RNA is a hotspot of cancer …

Although treatment of colorectal cancer with 5-florouracil and oxaliplatin is widely used, it is
frequently followed by a relapse. Therefore, there is an urgent need for profound …

Oxaliplatin (OXA)‑containing regimens are used as first‑line chemotherapy in colorectal
cancer (CRC). However, OXA resistance remains a major challenge in CRC treatment. CRC …

LUZP1 is a centrosomal and actin cytoskeleton-localizing protein that regulates both
ciliogenesis and actin filament bundling. As the cytoskeleton and cilia are implicated in …